Regeneron to buy genetic testing firm 23andMe for $256 million-February 2024-www.financetom.com

Regeneron to buy genetic testing firm 23andMe for $256 million

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Regeneron to buy genetic testing firm 23andMe for $256 million

May 26, 2025 10:07 AM

May 19 (Reuters) - Drugmaker Regeneron Pharmaceuticals

has agreed to buy genetic testing firm 23andMe Holding ( MEHCQ )

for $256 million, the companies said on Monday.

Previous page： Dixon Technologies to supply 20 million phones for Jio Bharat initiative, expects upto Rs 1,800 crore revenue from this by March Next page： IDEMIA seeks to promote financial inclusion through offline payment solutions, says VP of Digital Currencies

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Dixon Technologies to supply 20 million phones for Jio Bharat initiative, expects upto Rs 1,800 crore revenue from this by March

Sep 8, 2023

Dixon Technologies, under the leadership of Saurabh Gupta, is poised for significant growth, with promising opportunities on the horizon. The company's involvement in the Jio Bharat initiative, exploration of Jio laptops, and the potential global client deal all signify exciting developments.

IDEMIA seeks to promote financial inclusion through offline payment solutions, says VP of Digital Currencies

Sep 5, 2023

IDEMIA collaborates with more than 600 government entities and over 2,300 corporations spanning 180 countries worldwide.

Google Cloud partners with MeitY to train government officials in cybersecurity skills

Sep 7, 2023

The 'cyber force' of government officials will be trained in cyber defence best practices, including the use of generative AI, and conducting cybersecurity AI hackathons led by Google Cloud and Mandiant experts, the American technology giant said in a statement.

Apple inks new long-term deal with Arm for chip technology, shows filing

Sep 6, 2023

Apple has signed a new deal with Arm for chip technology that "extends beyond 2040," according to Arm's initial public offering documents